Overview
Ning Dong is a Hematologist Oncology specialist and a Hematologist in Issaquah, Washington. Dr. Dong is rated as an Experienced provider by MediFind in the treatment of Adult T-Cell Leukemia. Her top areas of expertise are Diffuse Large B-Cell Lymphoma (DLBCL), Non-Hodgkin Lymphoma, B-Cell Lymphoma, Bone Marrow Aspiration, and Lymphadenectomy. Dr. Dong is currently accepting new patients.
Her clinical research consists of co-authoring 19 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of Adult T-Cell Leukemia.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- PPO
- HMO
- POS
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
751 Ne Blakely Dr, Suite 1090, Issaquah, WA 98029
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
The Association Of University Physicians
Ryan Cassaday is a Hematologist Oncology specialist and a Hematologist in Seattle, Washington. Dr. Cassaday is rated as an Elite provider by MediFind in the treatment of Adult T-Cell Leukemia. His top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Leukemia, Non-Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Cassaday is currently accepting new patients.
Yoshihiro Inamoto is a Hematologist Oncology provider in Seattle, Washington. Dr. Inamoto is rated as a Distinguished provider by MediFind in the treatment of Adult T-Cell Leukemia. His top areas of expertise are Chronic Graft Versus Host Disease (cGvHD), Graft Versus Host Disease (GvHD), Adult T-Cell Leukemia, Bone Marrow Transplant, and Bone Graft.
The Association Of University Physicians
Danai Dima is a Hematologist Oncology specialist and a Hematologist in Seattle, Washington. Dr. Dima is rated as a Distinguished provider by MediFind in the treatment of Adult T-Cell Leukemia. Her top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Primary Amyloidosis, Agranulocytosis, and Splenectomy. Dr. Dima is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- B-Cell LymphomaDr. Dong isAdvanced. Learn about B-Cell Lymphoma.
- Bone Marrow AspirationDr. Dong isAdvanced. Learn about Bone Marrow Aspiration.
- Childhood Acute Myeloid Leukemia
- Cutaneous T-Cell Lymphoma (CTCL)
- Diffuse Large B-Cell Lymphoma (DLBCL)
- Drug-Induced ThrombocytopeniaDr. Dong isAdvanced. Learn about Drug-Induced Thrombocytopenia.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Dong isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Dong isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Acute Myelomonocytic LeukemiaDr. Dong isExperienced. Learn about Acute Myelomonocytic Leukemia.
- Acute Promyelocytic LeukemiaDr. Dong isExperienced. Learn about Acute Promyelocytic Leukemia.